Rachel Kim
Appearances
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
Indiana University School of MedicineIndiana University - DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
Indiana UniversityIndiana University School of Medicine - DateMay 6, 2023We present the case of a 67-year-old woman who had two IPMN in the pancreas body (4 and 2 cm) and underwent robotic distal pancreatectomy with spleen preservation…
Presenter
Speakers
- DateMay 19, 2024BACKGROUND: Accurate clinical staging plays a key role in the multimodal treatment of pancreatic ductal adenocarcinoma (PDAC)…
Presenter
Speakers
Indiana UniversityIndiana University School of Medicine - DateMay 21, 2024Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed after reaching an advanced stage. High-risk patients with genetic predisposition (ie…
